Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
Authors:
- 24 December 2010
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 258 (6) , 982-990
Abstract
Ghrelin, an orexigenic peptide, has multiple functions, which include promoting gastrointestinal motility and influencing higher brain functions. Experimental data suggest that ghrelin has neuroprotective potential in the MPTP mouse model of Parkinson’s disease (PD). PD patients show delayed gastric emptying and other symptoms that may relate to disturbed excretion of ghrelin. No data are available on postprandial ghrelin response in patients with PD and idiopathic REM sleep behaviour disorder (iRBD)––a condition considered a putative preclinical stage of PD. We measured fasting and postprandial ghrelin serum concentrations in 20 healthy controls, 39 (including 19 drug-naïve) PD patients and 11 iRBD patients using a commercial radioimmunoassay for total ghrelin. For statistical analysis we employed ANCOVA and post-hoc testing with Bonferroni’s method. Controls showed a decrease of mean fasting ghrelin serum concentrations in the early postprandial phase, followed by a recuperation starting 60 min after the test meal and reaching a maximum at 300 min. This recuperation was less pronounced in PD and iRBD; the slope of relative postprandial ghrelin recovery was different between the investigated groups (p = 0.007). Post-hoc testing showed a difference between controls and PD patients (p = 0.002) and between controls and iRBD patients (p = 0.037). The dynamic regulation of ghrelin in response to food intake is partially impaired in subjects at putative preclinical (iRBD) and clinical stages of PD. Reduced ghrelin excretion might increase the vulnerability of nigrostriatal dopaminergic neurons as suggested by animal studies. The impaired ghrelin excretion might qualify as a peripheral biomarker and be of diagnostic or therapeutic value.Keywords
This publication has 24 references indexed in Scilit:
- Real‐time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's diseaseMovement Disorders, 2010
- The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorderEuropean Journal of Neurology, 2010
- Effect of age and frailty on ghrelin and cholecystokinin responses to a meal testThe American Journal of Clinical Nutrition, 2009
- Pre- and post- prandial appetite hormone levels in normal weight and severely obese womenNutrition & Metabolism, 2009
- Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigraExperimental Neurology, 2008
- The orexigenic hormone ghrelin defends against depressive symptoms of chronic stressNature Neuroscience, 2008
- Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetiteJournal of Clinical Investigation, 2006
- Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for -synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECTBrain, 2004
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988